Working Group: Evidence Reports

• PCA3 Testing for the Diagnosis and Management of Prostate Cancer
  Blue Cross Blue Shield Technical Evaluation Center | April 2013
• Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review
  CDC/OPHG in collaboration with IPMMS | March 2013
• Systematic review of pharmacogenetic testing for predicting clinical benefit to anti-EGFR therapy in metastatic colorectal cancer
  Center for Health Research, Kaiser Permanente Northwest | June 2011
• Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies-A targeted evidence-based review.
  CDC/OPHG in collaboration with IPMMS | December 2010
• Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism [PDF 681 KB]
  The Johns Hopkins University Evidence Based Practice Center | June 2009
• Can UGT1A1 Genotyping Reduce Morbidity and Mortality in Patients with Metastatic Colorectal Cancer Treated with Irinotecan? [PDF 1.88 MB]
  CDC, in conjunction with IPMMS and RTI I January 2009
• EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
  CDC/OPHG in collaboration with IPMMS | January 2009
• Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
  The Johns Hopkins University Evidence Based Practice Center | January 2008
• Hereditary Nonpolyposis Colorectal Cancer: Diagnostic Strategies and Their Implications [PDF 7.57 MB]
  Tufts New England Medical Center Evidence Based Practice Center | May 2007
• Testing for Cytochrome P450 Polymorphisms (CYP450) in Adults with Non-Psychotic Depression Prior to Treatment with Selective Serotonin Reuptake Inhibitors (SSRIs) [PDF 944 KB]
  Duke University AHRQ Evidence-based Practice Center | January 2007
• Genomic Tests for Ovarian Cancer Detection and Management [PDF 2.01 MB]
  Duke University AHRQ Evidence-based Practice Center | October 2006